- Home
- CINT vs TECX Comparison
CINT vs TECX Comparison
Compare CINT & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CINT
- TECX
- Stock Information
- Founded
- CINT 1995
- TECX 2019
- Country
- CINT Brazil
- TECX United States
- Employees
- CINT N/A
- TECX N/A
- Industry
- CINT EDP Services
- TECX
- Sector
- CINT Technology
- TECX
- Exchange
- CINT Nasdaq
- TECX Nasdaq
- Market Cap
- CINT 932.1M
- TECX 746.6M
- IPO Year
- CINT 2021
- TECX 2018
- Fundamental
- Price
- CINT $7.37
- TECX $29.54
- Analyst Decision
- CINT Buy
- TECX Strong Buy
- Analyst Count
- CINT 6
- TECX 5
- Target Price
- CINT $7.72
- TECX $80.50
- AVG Volume (30 Days)
- CINT 124.8K
- TECX 661.7K
- Earning Date
- CINT 03-06-2025
- TECX 03-04-2025
- Dividend Yield
- CINT N/A
- TECX N/A
- EPS Growth
- CINT 15.05
- TECX N/A
- EPS
- CINT 0.16
- TECX N/A
- Revenue
- CINT $410,247,558.00
- TECX N/A
- Revenue This Year
- CINT $9.20
- TECX N/A
- Revenue Next Year
- CINT $14.92
- TECX N/A
- P/E Ratio
- CINT $45.19
- TECX N/A
- Revenue Growth
- CINT N/A
- TECX N/A
- 52 Week Low
- CINT $3.34
- TECX $1.40
- 52 Week High
- CINT $8.04
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- CINT 60.94
- TECX 38.91
- Support Level
- CINT $6.97
- TECX $30.42
- Resistance Level
- CINT $8.00
- TECX $36.11
- Average True Range (ATR)
- CINT 0.32
- TECX 3.49
- MACD
- CINT -0.02
- TECX -0.94
- Stochastic Oscillator
- CINT 49.60
- TECX 0.81
About CINT CI&T Inc
CI&T Inc is engaged in providing strategy, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.